FROM RUSSIA WITH LOVE, Gamaleya Sputnik V Efficacy Rate: 91.6% Developed by: Gamaleya National Research Centre of Epidemiology and Microbiology Shots Required: 2 doses, 3 weeks apart The Russian Government has already authorized its use since last year even before early-stage trial results (Nature Briefing), but despite the high efficacy rate, there have been ongoing controversies regarding this brand as rare side effects are in question and still seeking approval from the WHO.
ONE-SHOT WONDER, Janssen Efficacy Rate: 66.1 - 66.9% Developed by: Janssen Pharmaceuticals Companies of Johnson & Johnson Shots Required: 1 dose This FDA-approved vaccine is for emergency use and is known for its one-shot wonders. Though there have been certain cases wherein side effects include blood clots after receiving the vaccine.
INDIA’S MIRACLE, Covaxin-Bharat BioTech Efficacy Rate: 80.6% Developed by: collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). Shots Required: 2 doses, 28 days apart This underdog brand has shown promising results after its phase 3 trial and has been approved for emergency usage in India since its drastic increase in covid cases and other countries as well. The developers aim to create a vaccine that is affordable and safe.
59
EC Magazines | Summer Edition 2021
Made with FlippingBook Proposal Creator